When President George W. Bush gives his State of the Union Address on Tuesday evening, he’s more likely to talk about the soaring cost of health care than another pending crisis in medicine: the severe budget cuts for biomedical research.
In 2006, the National Institutes of Health (NIH), the country’s major funding agency for biomedical research, will face a budget cut for the first time since 1970. Scientists worry that the cuts could devastate research programs, stifle innovation, and discourage the next generation of researchers.
“We’re facing a serious crisis that may end up culling some of the very best people out of the biomedical research enterprise,” says Jack Feldman, a biologist at the University of California, Los Angeles. “There will be people who lose all funding or have gaps in funding so they can’t maintain the infrastructure they’ve built.”
The NIH will get $28.6 billion in fiscal 2006, a $35 million reduction from last year. The government had previously agreed to an increase of $206 million for the year, but that was wiped out with a bill that cut funding for discretionary spending by 1 percent across the board.
Overall, U.S. spending for research and development in fiscal 2006 totals $134.8 billion, a 1.7 percent increase over 2005. However, 97 percent of this increase is earmarked for defense weapons development and human space exploration technologies, according to an analysis by the American Association for the Advancement of Science (AAAS), a nonprofit organization based in Washington, DC. That leaves most agencies with cuts or modest increases falling short of inflation, according to AAAS.
The cuts could be particularly painful for NIH and biomedicine. While the agency’s budget doubled between 1998 and 2003, in the last two years, its funding has barely kept up with estimated inflation in the cost of biomedical research. The new budget effectively wipes out the gains since 2003, according to AAAS.
With the new cuts, scientists expect only one in ten grants to win funding, versus about three out of ten at the height of the NIH budget in 2003. Some worry that this crunch will discourage scientists from doing the most innovative kinds of research. “In order to get funded, you will need to write a perfect grant,” says Loren Frank, a professor of neuroscience at the University of California, San Francisco. “That means showing everything you propose is likely to work – and that’s what innovative research isn’t.”
“There were great opportunities unleashed by the doubling of the budget [between 1998 and 2003],” says Bruce Bistrian, president of the Federation of American Societies for Experimental Biology (FASEB), a coalition of research societies based in Bethesda, MD. “When you dramatically withdraw support, it has a disproportionate effect on the young, who don’t have the wherewithal to weather the storm.”
The NIH is attempting to temper the impact on new investigators by creating special mechanisms for reviewing first-time grant applicants.
The budget crisis could also affect the next generation of scientists. Many young people have been attracted to neuroscience by the prospect of curing diseases such as Alzheimer’s and Parkinson’s disease, according to Frank. “If students start perceiving they can do better in something else, they’ll go into programming or finance and we lose them to science,” he says.
President Bush’s budget plan for fiscal 2007 is expected to be released on February 6, 2006 (four days after his State of the Union Address). FASEB released a report on January 20 recommending a 5 percent increase for NIH in 2007 over the current year’s funding.
The severe cuts in NIH funding could eventually cause the President some pain. According to a poll released on January 26 by Research!America, a nonprofit advocacy group for medical research, based in Alexandria, VA, Americans currently rank health-related research (94 percent) as at least equal to homeland security (92 percent) in the nation’s priorities, and 51 percent want President Bush to ask for increased funding for health-related research in his 2007 budget request. It is a trend in public opinion, however, that the President has been ignoring.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.